Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02824861 · ClinicalTrials.gov registry record · NA
Bemobile Intervention to Support Physical Activity in Cancer Survivors
A NA study, sponsored by University of Vermont.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT02824861: Completed NA study, sponsored by University of Vermont.
NCT02824861 is a NA study that has completed, run by University of Vermont. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02824861, a NA study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This study evaluates a technology based intervention (physical activity tracker, text messages, health coach, global positioning system enabled location based feedback on physical activity) to support physical activity in cancer survivors after completing oncology rehabilitation. In Phase 1 all participants received the full intervention. In phase II participants are randomly assigned to receive the full intervention or a fitbit only.
Primary Outcome
Mean daily step counts as assessed by Actigraph Accelerometer
Interventions
- BEHAVIORAL Bemobile
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2015-07 |
| Est. Completion | 2018-11-01 |
| Phase | NA |
What the finished NCT02824861 record still lists
NCT02824861 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Bemobile is the first listed.
NCT02824861 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02824861 about?
NCT02824861 is a clinical study titled "Bemobile Intervention to Support Physical Activity in Cancer Survivors". This study evaluates a technology based intervention (physical activity tracker, text messages, health coach, global positioning system enabled location based feedback on physical activity) to support physical activity in cancer survivors after completing oncology rehabilitation. In Phase 1 all part...
What is the current status of trial NCT02824861?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2015-07. Estimated completion is 2018-11-01.
What interventions are being tested in trial NCT02824861?
The interventions under investigation include: Bemobile (BEHAVIORAL).
Who is sponsoring clinical trial NCT02824861?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02824861's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia